Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

The honey bee continues to play a key role in the life cycle of numerous flower varieties. Throughout a typical honey bee’s day – it’ll visit dozens, if not hundreds, of flowers and PhytoPharma‘s particular honey bees are no different. PhytoPharma International’s honey bees produce honey that is set apart from the rest of the buzzing insect kingdom due to its cannabinoid properties, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), which is the cannabinoid that does not produce a psychoactive effect, unlike THC. The company achieved this cannabinoid-rich honey through a process where the honey bees consume a created food amalgam that contains cannabidiols within it.

The process that the bees go through to create the honey is completely natural. A honey bee does not have a mammalian endocannabinoid system within its insect structure to process or utilize cannabinoids of any kind. This makes the Pure Bee honey product an entirely naturally made cannabis honey that does not use any injected or infused cannabis to create it. PhytoPharma’s harvested cannabinoid honey is then sold in sets of six or three pre-measured cooking syringes. Pure Bee CBD syringes come in .5 mg per gram and the psychoactive THC variant comes in at 0.7 mg per gram.

Learn more about PhytoPharma International and other hot cannabis companies. See our Cannin Report and subscribe to our Weekly Cannin Chronicle for more information and a FREE stock tip.